跳至主要内容
临床试验/NCT02608957
NCT02608957终止不适用

Evaluation of the Latella™ Knee Implant System for Medial Osteoarthritis Pain Reduction (Latella-US Study)

Cotera, Inc.4 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2015年12月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Cotera, Inc.
入组人数
1
试验地点
4
主要终点
Primary Safety Endpoint: Surgical re-intervention rate at 6 months

研究概览

简要总结

The objective of the Latella-US study is to demonstrate the safety and efficacy of the Latella Knee Implant System for the reduction of medial osteoarthritis pain.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of pain due to medial osteoarthritis
  • Qualifying baseline pain scores
  • Kellgren-Lawrence Grades 2-3

排除标准

  • Osteoporosis
  • Rheumatoid arthritis
  • Joint instability
  • Metal ion allergy
  • Permanent implant in or around the knee joint
  • Prior anterior cruciate ligament reconstruction

结局指标

主要结局

Primary Safety Endpoint: Surgical re-intervention rate at 6 months

时间窗: 6 Months

Surgical re-intervention rate during the 6 month period following implantation of the Latella device.

Primary Efficacy Endpoint: Mean change in KOOS pain score at 6 months

时间窗: 6 Months

Mean change in KOOS pain score at 6 months after treatment with the Latella Implant.

次要结局

  • Procedure-related complications rate(24 Months)
  • Change in KOOS function score(6, 12 and 24 months)
  • Change in IKDC score(6, 12 and 24 months)
  • Device-related complications rate(24 months)
  • Surgical re-intervention rate(12 and 24 months)
  • Change in KOOS pain score(12 and 24 months)
  • Change in medial knee pain NRS (while walking)(6, 12 and 24 months)
  • Proportion of subjects reaching MCID in KOOS pain score(6, 12 and 24 months)
  • KOOS responder rate based on OARSI-OMERACT criteria(6, 12 and 24 months)

研究者

发起方
Cotera, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验